Key Development
The Standing Committee of the National Assembly of Vietnam (NASC) is scheduled to convene its landmark 6th Official Session in September 2026 across two distinct operational phases: Phase 1 (September 3 afternoon – September 4 morning, 2026) and Phase 2 (September 21 – September 25 morning, 2026).
The comprehensive legislative agenda encompasses deliberative review and policy feedback across 27 major draft laws and statutory resolutions, featuring a heavy concentration of foundational Healthcare, Pharmaceutical, and Public Welfare statutory frameworks:
-
Core Healthcare, Pharmaceutical & Demographic Legislation:
-
Reviewing the Amended Law on Pharmacy; the Law amending and supplementing the Law on Medical Examination and Treatment; and the comprehensive Law on Population.
-
Deliberating the Amended Law on Food Safety, targeting enhanced digital post-market surveillance and cross-ministerial enforcement over dietary supplements.
-
Debating the Law amending and supplementing the Law on Prevention and Control of Tobacco Harms, focusing on statutory prohibitions and regulatory chokepoints against Electronic Nicotine Delivery Systems (e-cigarettes) and Heated Tobacco Products (HTPs).
-
-
Specialized Clinical & Social Welfare Frameworks:
-
Deliberating the Amended Law on Human Organ, Tissue Donation, and Transplantation.
-
Reviewing amendments across social protection statutes: Law on Children, Law on Persons with Disabilities, Law on Social Insurance, and the Amended Law on Occupational Safety and Health.
-
-
Legislative Program Enactments & Institutional Resolutions:
-
Enacting the Resolution on the 2027 Legislative Program; approving judicial salary scales; structuring cost-recovery allocations for state inspection agencies; evaluating the National Target Program on Crime Prevention (2026–2030, vision 2035); and concluding review of the 1st Extraordinary Session of the 16th National Assembly.
-
Why It Matters
-
Modernizing Pharmaceutical Market Authorization & Supply Chains (Law on Pharmacy): The proposed amendments directly address regulatory bottlenecks in Vietnam’s biopharma market: automating marketing authorization (MA) license renewals, streamlining raw material API imports, establishing transparent volume-price negotiation mechanisms for originator biologics, and establishing a statutory framework for licensed E-pharmacy retail tied to national electronic prescriptions.
-
Harmonizing Clinical Governance & Licensure Standards: Aligns statutory guidelines with the upcoming 2027 independent physician licensing examination administered by the National Medical Council, formalizes the 3-tiered healthcare delivery structure, and reinforces value-based medical service pricing models.
-
Regulatory Chokepoints on Illicit Vaping & Adulterated Supplements: Concurrent reviews of tobacco control and food safety statutes establish inter-agency enforcement mandates (spanning MOH, Ministry of Industry and Trade, and Police forces) to eliminate illicit next-generation tobacco distribution and penalize deceptive health supplement marketing.
Healthcare Insight Analysis
From the perspective of Healthcare Insight, the legislative deliberations set for the NASC 6th Session in September 2026 illustrate a Comprehensive Health Sector Legislative Overhaul.
The legislative session reflects three strategic reform vectors:
-
Transitioning from Pre-Market Administrative Red Tape to Digital Post-Market Oversight: Proposed amendments in Pharmacy and Food Safety laws reduce regulatory burdens on legitimate drug sponsors and importers while introducing data-driven post-market tracing and severe criminal penalties for non-compliance.
-
Balancing Clinical Innovation with Bioethical Transparency: Modernizing organ transplantation statutes establishes clear brain-death donation protocols and a centralized organ-sharing network, increasing organ availability while preventing illicit commercial trade.
-
Proactive Demographic Adaptation Amid Population Aging: The Law on Population fundamentally shifts policy from family planning (fertility limitation) toward replacement-fertility sustainment, population quality enhancement, and geriatric care infrastructure development.
Market Implications
-
Predictable Regulatory Pathways for Global and Domestic Pharma: Provides multinational and domestic drugmakers (MNCs and top-tier local manufacturers) with long-term clarity regarding clinical trial approvals, technology transfer incentives, and EU/Japan-GMP procurement criteria.
-
Elevated Compliance Standards for Pharmacy Chains & E-Commerce: Retail pharmacy networks (such as Long Chau, Pharmacity, An Khang) and digital platforms must upgrade compliance infrastructure to interface with national electronic prescription databases and food safety registries.
-
Catalyzing Private Healthcare Investment & Commercial Health Insurance: Transparent medical service pricing and updated social insurance provisions encourage public-private partnerships (PPP) and drive uptake of supplemental commercial health insurance plans.
Key Legislative Matrix: Health & Social Welfare Bills (NASC 6th Session)
| Statutory Bill | Sponsoring / Reviewing Body | Core Regulatory Objectives & Structural Reforms |
| Amended Law on Pharmacy | MOH / Committee on Social Affairs | Automated MA renewals; e-pharmacy regulation; price negotiation. |
| Law on Medical Exam & Treatment (Amend.) | MOH / Committee on Social Affairs | 2027 competency exam governance; 3-tier clinical delivery. |
| Law on Population | MOH / Committee on Social Affairs | Sustaining replacement fertility; aging adaptation; prenatal screening. |
| Amended Law on Food Safety | MOH, MOIT, MARD / Social Affairs | E-commerce dietary supplement oversight; misleading ad crackdowns. |
| Tobacco Harm Prevention Law (Amend.) | MOH / Committee on Social Affairs | Statutory prohibition/control of e-cigarettes (vapes) and HTPs. |
| Organ & Tissue Donation Law (Amend.) | MOH / Committee on Social Affairs | Expanding brain-death donation; national transparent allocation. |